Concepedia

Catherine Chodkiewicz

CC

5

Publications

470

Citations

5

H-Index

2004

Active since

Affiliations

Moffitt Cancer Center(Current)

CancerCare Manitoba

Hammersmith Hospital

Pitié-Salpêtrière Hospital

Sorbonne Université

Catherine Chodkiewicz is an author at Moffitt Cancer Center specializing in cancer therapeutics, pharmacotherapy, and medicine.

Top concepts

Publications per year

2004–2009

5

Publications

5

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

, , +6

A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette et al. · Clinical Cancer Research · 2007 · 148 citations

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

Harpreet Wasan, Gregory M. Springett, Catherine Chodkiewicz et al. · British Journal of Cancer · 2009 · 43 citations · Full text

A randomized phase II study of axitinib (AG-013736) and gemcitabine versus gemcitabine in advanced pancreatic cancer, preceded by a phase I component

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · Journal of Clinical Oncology · 2007 · 18 citations

, , +16

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor

Anna C. Pavlick, Catherine Chodkiewicz, Leonard Liebes et al. · Anti-Cancer Drugs · 2004 · 12 citations

Rows per page

1–5 of 5